Supporting Parents in Affirming Their Children's Experiences of Stigma

Study acronym: SPACES
StatusCompleted
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 1 entry Show 7 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Aug 1, 2026 to May 12, 2026
    • Enrollment target: estimated 129 to confirmed 132
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 15 of 18 entries
    • Site details revised at 4 of 4 sites
    • Publications: details revised at 13 of 17 entries
  2. Phase: Not applicable to Phase 1
    • Study completion date: Aug 30, 2026 to Aug 31, 2026
    v11
  3. Primary completion date: Mar 2026 to Aug 1, 2026
    • Study completion date: Mar 2026 to Aug 30, 2026
    • Start date: Sep 10, 2024 to Nov 29, 2023
    v10
  4. Primary and study completion dates: May 2025 to Mar 2026v9
  5. Start date changed from estimate of Aug 2024 to Sep 10, 2024
    • Collaborators reordered
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jul 2024 to Aug 2024
    • Site details revised at 4 of 4 sites
    v7
  2. Start date: Apr 2024 to Jul 2024v6
  3. Start date: Jan 2024 to Apr 2024
    • Study completion date: Jun 2026 to May 2025
    • Study description expanded, about 10 words
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Study title shortened, about 3 wordsv3
  6. Start date: Jul 2023 to Jan 2024v2 Show 4 more changesShow less
    • Eligibility criteria shortened, about 17 words
    • Secondary endpoints: 12 to 18
    • Study description shortened, about 482 words
    • Publications: 13 to 17
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yale University
490 trials monitored
See 31 trials at risk
The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States.
Trial Details
NCT Number NCT05919849
Lead Sponsor Yale University
Collaborators: University of Maryland, Vanderbilt University, Ben-Gurion University of the Negev, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)		 Parent-Child Relations
Related terms Coitus
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov